culture was then transferred to the test wells. 75 L of sterile single strength LB broth was transferred to the negative control wells. Final volume for each well was 150 L.
The plates containing bacteria were covered and incubated at 37 o C shaking at 100 rpm for 18 h. The plates containing yeast were covered and incubated at 30 o C shaking at 100 rpm for 24 h. After incubation, 10 L of resazurin stock solution was added to all wells. The plates were then incubated for a further 1 h at 37 o C shaking at 100 rpm. Fluorescence was measured (excitation 485 nm, emission 535 nm) using a Fluoroskan Ascent microplate fluorometer (Thermo Scientific, Victoria, Australia). Each concentration of antibiotics used was repeated in triplicate and assays were performed on three separate occasions.
Data analysis
Percentage viability (relative to vehicle controls) was calculated from corrected fluorescent values. The MIC value of antibiotic controls and test compounds were determined as the first dilution at which at least 90% of growth was inhibited (MIC 90 ). Results are represented as the median value of replicate experiments.
Statistical analysis was performed using GraphPad Instat 3 (GraphPad Software, San Diego, CA, USA) on median value of the replicated experiments (triplicates). The KruskalWallis non-parametric analysis of variance on ranks was used to determine whether there were significant differences among susceptibilities. Mann-Whitney tests were performed to determine specific differences between antibiotics and test compounds (Mann-Whitney test). Differences were considered significant when P < 0.05.
Antitubercular Studies

Materials and Methods
The antitubercular activity testing was conducted at the Centenary Institute of Cancer Medicine and Cell Biology (NSW, Australia) using methods adapted from Collins et al. The H37Ra (ATCC 25177) clinical strain of M. tuberculosis was used to screen for antitubercular activity. Reference: L. Collins, S.G. Franzblau, Antimicrob. Agents Chemother., 1997, 41(5) , 1004-9.
Stock solutions of the test compounds were prepared in DMSO and diluted twofold with 7H9GC broth (no Tween 80) to prepare final concentrations ranging from 2 g/mL to 1000 g/mL. Suitable vehicle controls were included. Antitubercular testing was performed in 96 well black plates (back view plates; Packard Instruments Company, Meriden, Conn) in order to minimize background fluorescence. The outer well of the 96 well black plates were filled with sterile water to prevent dehydration of the experimental wells.
Frozen H37Ra was initially diluted 1:20 in BACTEC 12B medium, followed by a 1:50 dilution in 7H9GC. This culture was added to the wells at a final bacteria titre of 50,000 CFU/mL. Wells containing drugs alone were included to detect and account for autofluorescence of test compounds. Additional controls included bacteria and medium only containing wells. Plates were incubated at 37°C and at day 14, 20 L of 10 × AlamarBlue® solution (Alamar biosciences/Accumed, Westlake, Ohio) and 12.5L of 20% Tween 80 were added to all wells. The plates were then incubated for a further 24 h at 37°C. Following which fluorescence was measured at excitation of 530 nm and emission at 590 nm on a fluorescence microplate reader. Experiments were conducted in triplicate.
Data analysis
Results shown in Figure 1 were calculated as the percentage growth relative to vehicle controls and represented as the mean ± SD. Statistical analysis was performed with one-way ANOVA followed by Dunnett's post-test. Statistical significance was accepted at a probability level of P < 0.05. An MIC 50 of 25 M was set as the threshold for activity of interest. Only compound 5 (entry 8a below) displayed significant activity. (n=3) and SD were <5%. Note: Entry 8a is compound 5 in text, entry 8b is compound 6 in text, entry 10 is compound 7 in text, entry 12 is compound 8 in text.
Cellular Toxicity Studies
Materials
The synthesised compounds 5-8 were dissolved in DMSO at a concentration of 1 mM. Stock solutions were aliquoted and stored at 2-4°C and used within 1 month of preparation. These were screened for cytotoxic effects against adherent A549, MCF-7, and HeLa cell lines using sulforhodamine B (SRB) colorimetric assay. A549, MCF-7, and HeLa cell lines were obtained from ATCC (Manassas VA, USA). Complete Dulbecco's Modified Eagle Medium (DMEM)/F12, DMEM, high glucose RPMI 1640 medium, L-glutamine, sodium pyruvate, HEPES, and Penicillin-Streptomycin solution were purchased from Invitrogen (Victoria, Australia). All other chemicals and reagents were of analytical grade and sourced from Sigma Aldrich (St Louis, MO, USA). MilliQ water was sterilized by autoclaving at 121°C for 20 min. 96 well plates used in this study were purchased from Nunc (New York, USA).
Cell cultures
Adherent A549 cells were grown and maintained at 37C with 5% CO 2 in complete DMEM/F12 supplemented with 10% fetal bovine serum (FBS) and 500 U/mL PenicillinStreptomycin. Adherent HeLa and MCF-7 cells were grown and maintained at 37
• C with 5% CO 2 in DMEM medium supplemented with 10% FBS, 2 mM L-glutamine and 500U/mL Penicillin-Streptomycin.
Cell viability assay
For screening of the test compounds, cells were seeded at 1 × 10 4 trypan blueexcluding cells/mL in 96 well microtiter plates. 180 L of cells, at appropriate cell density, were transferred to all experimental wells. 20 L of the test compounds (at final concentrations of 5, 50 and 100 M) or vehicle controls were added to each well, making up a final volume of 200 L. Concentrated stock solutions of the test compounds were prepared in DMSO ensuring that the final solvent concentration remained below 1%. DMSO concentrations below 1% were shown to not affect cell viability of any of the tested cell lines during assay validation. Percentage cell viability was then assessed by either the colorimetric sulforhodamine B (SRB) or fluorescent-based resazurin assays. The SRB colorimetric assay was used as the primary measure of cell viability for adherent A549, HeLa, and MCF-7 cells. SRB is a protein staining assay, which measures the cellular protein content of adherent or suspension cultures. SRB is a bright pink aminoxanthene dye with two sulfonic groups. Under acidic conditions, the two sulfonic groups bind to basic amino acids of cellular proteins, providing a colorimetric evaluation of the estimated total protein mass in relation to the cell number. The SRB assay has been shown to detect cell densities as low as 1,000 to 2,000 cells per well, with sensitivity comparable with several routinely used fluorescent assays. In addition, the SRB assay exhibits linearity over a dynamic range of cell densities.
The SRB assay kits were purchased from Sigma Aldrich (St Louis, MO, USA). The cells were treated with test compounds for 24 h for screening. After which, 50 L of the 50% trichloroacetic acid (TCA) solution was added to each well to growth medium and incubated for 1 h at 4°C to fix the cells. The supernatant was removed and cells washed several times with water to remove TCA and serum proteins. Plates were subsequently air dried overnight. 50 L of SRB staining solution was added to cells for 20 min and then removed by washing with 1% acetic acid solution until all unincorporated dye was removed. Plates were again air dried overnight. 200 L of Tris base solution was added to each well and incubated for 5 min at room temperature on a IKA gyrator shaker (Crown Scientific, Minto, NSW) to enhance dye mixing. Absorbance was measured using a Titertek Multiskan MKII absorbance plate reader (Huntsville, USA) at an absorbance of 492 nm.
Data analysis
The test compounds were screened at concentrations of 5, 50 and 100 M. Cell viability was determined by comparing fluorescence of treatment wells to their respective vehicle controls. Results were calculated and represented as the percentage viable cells, relative to vehicle controls. Reported values represent the mean ± S.E.M of replicate experiments performed on different days. Statistical analysis was performed using GraphPad Instat 3 (GraphPad Software, San Diego, CA, USA). One-way ANOVA followed by Dunnett's test were used to assess statistical differences between treatments. Statistical significance was accepted at a probability level of P < 0.05.
Results
The effect of compounds 5-8 on percentage viability of HeLa human cervical carcinoma cells is presented in Figure S2 . These results are discussed in the paper. . Symbols (*) and (***) indicate statistical significance of P < 0.05 and P < 0.001, respectively, as compared to vehicle control.
The effect of compounds 5-8 on percentage viability of A549 human alveolar adenocarcinoma cells is presented in Figure S3 . All compounds appeared to affect A549 cell viability in a concentration-dependent manner; however, observations were only statistically significant for compounds 5 and 8. Statistically significant reductions in cell viability were observed at both 50 (28.8 ± 7.3%) and 100 M (31.6 ± 7.4%) concentrations for compound 5. Compound 8 produced maximal observed inhibitory effect, reducing A549 cell viability by 50 ± 12.5% at the concentration of 100 M (P < 0.05). Although 50 M of compound 8 reduced viability by 23.3 ± 13.31%, this observation was not statistically significant. Compounds 6 and 7 tended to reduce viability at 50 and 100 M concentrations, however, these observed effects were not statistically significant when compared to vehicle controls (P > 0.05). Reduction in A549 cell viability at the 100 M concentration were 30.7 ± 11.2% and 24.1 ± 12.5% for compounds 6 and 7, respectively. The effect of compounds 5-8 on percentage viability of MCF-7 human breast adenocarcinoma cells is presented in Figure S4 . Compounds 5 and 7 tended to produce a subtle, but not statistically significant, reduction in viability of MCF-7 cells. At concentrations of 100 M, compounds 6 and 8 reduced viability by 27.9 ± 10.2% (P < 0.05) and 41.0 ± 9.5% (P < 0.01), respectively. No significant alterations in cell viability were observed for lower concentrations of compounds 6 and 8. . Symbols (*) and (**) indicate statistical significance of P < 0.05 and P < 0.01, respectively, as compared to vehicle controls.
